Management of heart failure with reduced ejection fraction in Europe: design of the ARIADNE registry

Journal Article published Apr 2020 in ESC Heart Failure volume 7 issue 2 on pages 727 to 736

Research funded by Novartis Pharmaceuticals UK Limited

Authors: Uwe Zeymer, Andrew L. Clark, Vivencio Barrios, Thibaud Damy, Jaroslaw Drożdż, Candida Fonseca, Lars H. Lund, Gabriele Di Comite, Stephan Hupfer, Aldo P. Maggioni

Dithiane-directed Rh(iii)-catalyzed amidation of unactivated C(sp3)–H bonds

Journal Article published 2019 in Chemical Science volume 10 issue 13 on pages 3733 to 3737

Research funded by Engineering and Physical Sciences Research Council (EP/L015838/1) | AstraZeneca | Diamond Light Source | Defence Science and Technology Laboratory | GlaxoSmithKline | Novartis Pharmaceuticals UK Limited

Authors: Heyao Shi, Darren J. Dixon

Cost Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK

Journal Article published Jul 2018 in PharmacoEconomics volume 36 issue 7 on pages 867 to 878

Research funded by Novartis Pharmaceuticals UK Limited

Authors: Vanessa Buchanan, Will Sullivan, Chris Graham, LaStella Miles, Steffen Marc Jugl, Praveen Gunda, Anna Halliday, Bruce Kirkham

Reply

Journal Article published Mar 2019 in Journal of Allergy and Clinical Immunology volume 143 issue 3 on pages 1265 to 1266

Research funded by British Microcirculation Society | National Institute for Health Research | Roche | Wellcome Trust (WT082265098351/Z/12/Z) | Genentech | GlaxoSmithKline | Chiesi Farmaceutici | Medical Research Council (MR/J00345X/1) | AstraZeneca | Boehringer Ingelheim | Asthma UK | Pfizer UK | Novartis Pharmaceuticals UK Limited | MedImmune | Cambridge National Institute for Health Research (NIHR) Biomedical Research Centre | AirPROM 7th EU Framework grant | Leicester NIHR Biomedical Research Centre | AirPROM | Mologic | BMS

Authors: Neda Farahi, Chrystalla Loutsios, Nicola Tregay, Adam K.A. Wright, Rachid Berair, Laurence S.C. Lok, Daniel Gillett, Ian Cullum, Rosalind P. Simmonds, Charlotte Summers, Anna Wong, Chandra K. Solanki, John Buscombe, Pee Hwee Pang, Arthikkaa Thavakumar, A. Michael Peters, Christopher E. Brightling, Alison M. Condliffe, Edwin R. Chilvers

This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols

Journal Article published Dec 2019 in Trials volume 20 issue 1

Research funded by Medical Research Council (171339, 171339 and 171339) | Efficacy and Mechanism Evaluation Programme (11/100/50) | Cancer Research UK (A13363 and 162082) | Novartis Pharmaceuticals UK Limited (158519) | Janssen Pharmaceuticals (163301) | Astellas Pharma US (163026) | AstraZeneca (158046)

Authors: Francesca Schiavone, On behalf of past and present members of the STAMPEDE and FOCUS4 Trial Management Group, Riya Bathia, Krishna Letchemanan, Lindsey Masters, Claire Amos, Anna Bara, Louise Brown, Clare Gilson, Cheryl Pugh, Nafisah Atako, Fleur Hudson, Mahesh Parmar, Ruth Langley, Richard S. Kaplan, Chris Parker, Gert Attard, Noel W. Clarke, Silke Gillessen, Nicholas D. James, Tim Maughan, Matthew R. Sydes

Rhodium-catalysed vinyl 1,4-conjugate addition coupled with Sharpless asymmetric dihydroxylation in the synthesis of the CDE ring fragment of pectenotoxin-4

Journal Article published 2019 in Chemical Science volume 10 issue 25 on pages 6336 to 6340

Research funded by Engineering and Physical Sciences Research Council (EP/L015838/1) | AstraZeneca | Diamond Light Source | Defence Science and Technology Laboratory | GlaxoSmithKline | Novartis Pharmaceuticals UK Limited | Pfizer UK | UCB UK

Authors: Melodie S. W. Richardson, Christopher J. Tame, Darren L. Poole, Timothy J. Donohoe

Training in health coaching skills for health professionals who work with people with progressive neurological conditions: A realist evaluation

Journal Article published Aug 2020 in Health Expectations volume 23 issue 4 on pages 919 to 933

Research funded by Novartis Pharmaceuticals UK Limited | Health and Care Research Wales

Authors: Freya Davies, Fiona Wood, Alison Bullock, Carolyn Wallace, Adrian Edwards

Paucity and Inconsistency: A Systematic Review and Critique of Budget Impact Analyses of Disease-Modifying Therapies for Multiple Sclerosis in the UK and the Implications for Policy in the UK

Journal Article published Oct 2016 in Applied Health Economics and Health Policy volume 14 issue 5 on pages 545 to 558

Research funded by Novartis Pharmaceuticals UK Limited (GB)

Authors: Stephen Montgomery, Jeanette Kusel, Felicity Allen, Nicholas Adlard

Systematic Assessment of Difficult-to-Treat Asthma: Principles and Perspectives

Journal Article published Jul 2020 in The Journal of Allergy and Clinical Immunology: In Practice volume 8 issue 7 on pages 2222 to 2233

Research funded by GlaxoSmithKline | AstraZeneca | Novartis | Teva Pharmaceutical Industries | Sanofi | Novartis Pharmaceuticals UK Limited | Alfred Health | Seqirus | Joan Bending | Evelyn Bending | Mervyn Stephens | Olive Stephens Memorial Fellowship

Authors: Mark Hew, Andrew Menzies-Gow, James H. Hull, Louise Fleming, Celeste Porsbjerg, Anneke Ten Brinke, David Allen, Robin Gore, Tunn Ren Tay

Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK

Journal Article published Sep 2018 in British Journal of Haematology volume 182 issue 6 on pages 777 to 788

Research funded by Novartis Pharmaceuticals UK Limited

Authors: Nicholas C. P. Cross, Helen E. White, Paul A. S. Evans, Jeremy Hancock, Mhairi Copland, Dragana Milojkovic, Joanne Mason, Sandra Craine, Adam J. Mead